Amdocs Limited (NASDAQ:DOX) Receives Average Rating of “Moderate Buy” from Analysts

Shares of Amdocs Limited (NASDAQ:DOXGet Free Report) have been given a consensus rating of “Moderate Buy” by the five ratings firms that are presently covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold rating and four have given a buy rating to the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $101.20.

Separately, StockNews.com cut Amdocs from a “strong-buy” rating to a “buy” rating in a research report on Friday, February 28th.

Read Our Latest Stock Analysis on DOX

Hedge Funds Weigh In On Amdocs

A number of large investors have recently bought and sold shares of DOX. AdvisorNet Financial Inc raised its stake in shares of Amdocs by 382.9% during the 1st quarter. AdvisorNet Financial Inc now owns 338 shares of the technology company’s stock worth $31,000 after buying an additional 268 shares during the period. NBC Securities Inc. purchased a new position in Amdocs during the first quarter valued at $31,000. Jones Financial Companies Lllp acquired a new stake in shares of Amdocs in the fourth quarter valued at about $36,000. SBI Securities Co. Ltd. purchased a new position in shares of Amdocs during the 4th quarter worth $41,000. Finally, Global Retirement Partners LLC boosted its position in shares of Amdocs by 45.6% during the 4th quarter. Global Retirement Partners LLC now owns 559 shares of the technology company’s stock valued at $48,000 after acquiring an additional 175 shares during the last quarter. Institutional investors and hedge funds own 92.02% of the company’s stock.

Amdocs Price Performance

NASDAQ DOX opened at $83.18 on Friday. Amdocs has a 12-month low of $74.41 and a 12-month high of $93.34. The firm’s fifty day simple moving average is $87.40 and its two-hundred day simple moving average is $87.12. The company has a current ratio of 1.16, a quick ratio of 1.20 and a debt-to-equity ratio of 0.22. The firm has a market capitalization of $9.39 billion, a P/E ratio of 19.30, a P/E/G ratio of 1.47 and a beta of 0.59.

Amdocs (NASDAQ:DOXGet Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The technology company reported $1.45 earnings per share for the quarter, missing the consensus estimate of $1.64 by ($0.19). Amdocs had a return on equity of 18.89% and a net margin of 10.19%. Analysts forecast that Amdocs will post 6.21 EPS for the current fiscal year.

Amdocs Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Shareholders of record on Monday, March 31st will be issued a $0.527 dividend. The ex-dividend date is Monday, March 31st. This is an increase from Amdocs’s previous quarterly dividend of $0.48. This represents a $2.11 dividend on an annualized basis and a yield of 2.53%. Amdocs’s payout ratio is presently 48.72%.

Amdocs Company Profile

(Get Free Report

Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.

Read More

Analyst Recommendations for Amdocs (NASDAQ:DOX)

Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.